3 Liver Disease Case Challenges: Transplant, Steatohepatitis, Cirrhosis

Find details on US colorectal cancer screening rates, dietary interventions for people with IBS, and research on the primary drivers of cost of IBD care.

Severe outcomes may ensue in a high percentage of patients. The authors discuss the consequences in this brief podcast.

Results from secondary analysis suggest future work is needed to extend the prevention intervention to address additional chronic conditions and substance use.

Recurrent C difficile requires pulse vancomycin therapy; fecal microbiota transplant shows promise.

Vedolizumab for subcutaneous injection in now indicated for maintenance therapy following IV induction in both Crohn disease and ulcerative colitis.

Submission based on results from the phase 3 QUASAR induction study, which showed statistically significant and clinically meaningful improvements in symptoms.